Advertisement
Loading...

Penumbra, Inc.

PEN•NYSE
Healthcare
Medical - Devices
$322.32
$-0.65(-0.20%)
U.S. Market opens in 37h 54m

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.7B
P/E Ratio74.00
EPS (TTM)$4.33
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$348.28
3 Months$314.43
1 Year Target$280.73

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 74.00 and a market capitalization of 12.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.17%
5-Day Change
-0.77%
1-Month Change
-3.01%
3-Month Change
-4.98%
6-Month Change
15.12%
Year-to-Date (YTD) Change
3.70%
1-Year Change
17.10%
3-Year Change
2.38%
5-Year Change
37.20%
All-Time (Max) Change
680.65%

Contact Information

https://www.penumbrainc.com
510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

4,500 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions